Csaba Kantor News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Csaba kantor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Csaba Kantor Today - Breaking & Trending Today
Glenmarks Ryaltris®- innovative single nasal spray, ready to market in Russia MUMBAI, India, Feb. 22, 2021 /PRNewswire/ Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty S A, received marketing approval from the Ministry of Health of the Russian Federation for its innovative Ryaltris® Nasal Spray - a novel fixed-dose combination nasal spray. This paves the way for commercialization of Ryaltris® in Russia which is expected to be made available to patients in the country in Q1 FY 2021-22. Ryaltris® (olopatadine hydrochloride 665 mcg and mometasone furoate 25 mcg) is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis in adults and children over 12 years of age. Ryaltris® relieves symptoms of allergic rhinitis, including stuffy nose, runny nose, nasal itching, sneezing, as well as itchy, red and watery eyes. ....
Mumbai (Maharashtra) [India], February 22 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty SA, received marketing approval from the Ministry of Health of the Russian Federation for its innovative Ryaltris® Nasal Spray - a novel fixed-dose combination nasal spray. ....
Glenmark arm gets Russian Health Ministry nod for nasal spray Ryaltris February 22, 2021 Glenmark Pharmaceuticals on Monday said its Swiss subsidiary has received marketing approval from the Russian health regulator for its nasal spray Ryaltris. Ryaltris is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis in adults and children over 12 years of age. The drug relieves symptoms of allergic rhinitis, including stuffy nose, runny nose, nasal itching, sneezing, as well as itchy, red and watery eyes. “Glenmark Specialty received marketing approval from the Ministry of Health of the Russian Federation for its innovative Ryaltris Nasal Spray a novel fixed-dose combination nasal spray. This paves the way for commercialisation of Ryaltris in Russia which is expected to be made available to patients in the country in Q1FY2021-22,” Glenmark Pharmaceuticals said in a regulatory filing. ....
2021-02-22 11:05:18 GMT2021-02-22 19:05:18(Beijing Time) Xinhua English MUMBAI, Feb. 22 (Xinhua) India s drug maker Glenmark Pharmaceuticals has received marketing approval from the Russian health ministry to sell its novel fixed dose combination nasal spray, according to its corporate filing on Monday. The nasal spray, indicated for symptomatic treatment of seasonal and perennial allergic rhinitis in adults and children over 12 years of age, relieves symptoms of allergic rhinitis, including stuffy nose, runny nose, nasal itching, sneezing, as well as itchy, red and watery eyes. Allergic rhinitis, which can impact a person s quality of life and lead to functional impairments, as well as increase the risk of having asthma, is said to affect a certain proportion of the Russian population. ....